Clinical Trial Update: Lithium for Suicidal Behavior in Mood Disorders [Phase 2, Phase 3]

View source ↗

Summary

The clinical trial update covers lithium for suicidal behavior in mood disorders across Phase 2 and Phase 3. The study has been terminated and results have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Depressive Disorder

Drugs mentioned

• Lithium carbonate (Lithium carbonate)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Depressive Disorder, Bipolar Disorder | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2021-06-24